Dr Paul Jarrett and Dr Michel Nieuwoudt Photo: SUPPLIED
Skin cancer is the most common cancer in New Zealand and our rate of melanoma - the most serious type of skin cancer - is the highest in the world, with about 70% of cases diagnosed in people over 50.
Dr Michel Nieuwoudt is both a research scientist at Auckland University and an entrepreneur. As co-founder of Luminoma, she is a finalist in this year's KiwiNet Awards for her work on developing a commercially viable diagnostic tool that can identify skin cancers within seconds.
Also working on the project is Dr Paul Jarrett, Clinical Head of Dermatology at Middlemore Hospital and former President of the New Zealand Dermatological Society.
They speak to Mihi about what people should look out for and the difference this tool could make to early detection and treatment.
The Luminoma alpha prototype Photo: Luminoma Ltd
